Jonathan I. Lieber - 15 Feb 2024 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Chief Financial Officer
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
15 Feb 2024
Net transactions value
$0
Form type
4
Filing time
16 Feb 2024, 18:20:24 UTC
Previous filing
16 Mar 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +120,000 $0.000000 120,000 15 Feb 2024 Common Stock 120,000 $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 15, 2028.